In our earlier studies, we demonstrated that 30% of GBM lack the expression of ASS1 and depleting arginine using pegylated arginine deiminase (ADI-PEG20) resulted in cell death in vitro and tumor regression in an orthotopic xenograft model (19–20). The gene discussed is ASS1; the disease is neoplasm.